Health Care: Drugs

United Therapeutics Corp (UTHR: NASDAQ)

$170.11 -2.82 | -1.63%
07/02/15 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 170.11
52 Week High 190.29
52 Week Low 86.04
Avg. Daily Vol. (Mil) 0.66
Beta (3 year) 1.43
Share Related Items
Mkt Cap (Mil) 7,862.71
Shares Out (Mil) 46.26
Float (Mil) 38.96
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 1.30
Current Ratio 1.50
LT Debt/ Equity 0.00
Total Debt / Equity 0.11
Valuation Ratios
Price Earnings 50.50
Price/Sales 5.93
Price/Book 7.21
Price/Cash Flow 33.50
Per Share Data
Earnings 3.37
Sales 28.68
Book Value 23.60
Cash Flow 5.07
Business Summary
United Therapeutics Corp is a biotechnology company. The Company is engaged in thedevelopment and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening conditions.
General Information
1040 Spring Street
Silver Spring, MD 20910
www.unither.com
Industry : Drugs
Sector: Health Care
Employees: 740
CEO: Roger A. Jeffs,PhD
Short Interest
Current Month (Mil) 6.68
Previous Month (Mil) 6.74
Short Interest Ratio (Days) 11.20
Management Effectiveness
Return on Equity 17.00
Return on Assets 9.80
Return on Investments 17.00
Profitability
Gross Margin 94.90
EBIT Margin 23.40
Profit Margin 14.00

Portfolios with UTHR

Latest UTHR Headlines from TheStreet

More Financial News for UTHR

Press Releases for UTHR

See All Press Releases

Partner Headlines for UTHR

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter